268
+2.29%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Softmax Co
Its shares trade on Tokyo Stock Exchange under the ticker 3671.T. It has been listed since 6 February 2013. In the fiscal year to 31 December 2025, it reported revenue of ¥6.93bn and net income of ¥573.5m. At that date it held total assets of ¥9.13bn and shareholders' equity of ¥3.93bn.
Softmax Co., Ltd. engages in the development and sale of comprehensive medical information systems that include electronic health record, ordering, and medical accounting systems. The company is headquartered in Shinagawa-Ku, Tokyo-To. The company went IPO on 2013-02-06. The firm has system software, hardware and maintenance service business. System software business provides record of patient's medical information, instructions of examination and medication, medical accounting and other series of systems to make streamlining work in the hospital for medical institutions. It's systems include electronic medical record system, ordering system, medical accounting system, and other department support systems such as health examination system and rehabilitation system. Hardware business also sells hardware, including server and personal computer (PC) terminal necessary for system operation. Maintenance service business engages in user support after introduction, maintenance service and sales of expendable supply.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Technology
- Listed since
- 6 Feb 2013
- Employees
- 200
- Website
- s-max.co.jp ↗
Leadership
Pay as last reported
- Mr. Toshiro NomuraChairman of the Board, Representative Director, since 2001
- Ms. Chieko ShimamoriPresident, Representative Director, since 2001
- Mr. Tsutomu MatsushimaVice Chairman of the Board, since 2014
- Mr. Koichi HamahiraManaging Director, since 2008
- Mr. Tatsuhiko NomuraManaging Director, since 2018
- Mr. Katsuji SaitoManaging Director, since 2010
- Mr. Munetoshi NagasawaDirector of Central Japan Business Unit in Main Business Unit, Director, since 2020
- Mr. Kazushi ShimotamariSenior Director of 1st System Development Unit, Director, since 2017
- Mr. Daisuke UedaDirector of Business Planning in Main Administration Unit, Director, since 2016
- Mr. Takashi AikoIndependent Director
- Mr. Shinichi FukumotoIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Softmax Co Ltd employs 200 full-time employees in Shinagawa-ku, Tokyo-To.
- Softmax offers comprehensive medical information systems including electronic health records and medical accounting.
- Softmax provides system software, hardware, and maintenance services for hospitals.
Weaknesses
- Softmax's business is limited to Japan with no international presence.
- Softmax's IPO date was 6 February 2013, indicating a relatively young market presence.
- Softmax's employee count of 200 is modest compared to larger competitors.
Opportunities
- Softmax can expand its system software offerings to include advanced medical AI applications.
- Softmax may leverage Japan's aging population to increase demand for medical information systems.
- Softmax could partner with healthcare providers in Tokyo-To to enhance service delivery.
Threats
- Softmax faces competition from established healthcare IT firms in Japan.
- Softmax's reliance on Japan's healthcare sector makes it vulnerable to regulatory changes.
- Softmax's small employee base may hinder rapid scaling during market growth.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.